Data / Form D filings / Iyuda Therapeutics, Inc.
Iyuda Therapeutics, Inc.: Form D filings
Iyuda Therapeutics, Inc., a biotechnology company in Owings Mills, MD, filed 6 Form D notices with the SEC between 2023 and 2026. The latest, on April 6, 2026, reports $599,999 sold of a $599,999 offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3217 Hunting Tweed Dr., Owings Mills, MD, 21117
- Phone
- (202) 913-8697
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1993594
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 6, 2026 | New notice | $599,999 | $599,999 | 2 | Mar 23, 2026 | sec.gov | |
| Jun 6, 2025 | Amendment | $1,312,337 | $1,312,337 | 3 | Oct 1, 2024 | sec.gov | |
| Oct 21, 2024 | New notice | $952,338 | $952,338 | 3 | Oct 1, 2024 | sec.gov | |
| Sep 14, 2023 | New notice | $342,722 | $342,722 | 4 | Aug 30, 2023 | sec.gov | |
| Sep 14, 2023 | New notice | $1,385,262 | $1,385,262 | 1 | Sep 1, 2023 | sec.gov | |
| Sep 14, 2023 | New notice | $899,980 | $899,980 | 1 | Aug 30, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert Tennant | Executive Officer | Chief Executive Officer |
| Ephraim Fuchs | Director |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
Every Form D from the week of Apr 6, 2026 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Iyuda Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.